Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Companies
  4. /
  5. Ligne St. Barth SAS, St Barthelemy, France – FDA Inspections
Company
•France

Ligne St. Barth SAS, St Barthelemy, France – FDA Inspections

Inspection records and compliance data for Ligne St. Barth SAS in St Barthelemy. 1 FDA inspection on record (1 OAI), last inspected March 06, 2013.

Sign in to open in Dashboard
Company Profile

This profile covers Ligne St. Barth SAS based in St Barthelemy, France.

FDA Inspection History

FDA inspections
1
OAI
1
VAI
0
NAI
0
Form 483s
0
Warning letters
0

Inspected March 6, 2013.

FDA inspections (1)

DateResultFDA center(s)Insp. #
March 6, 2013OAIHuman Drugs · Drug Quality Assurance821620
FDA documents

No Form 483s, Warning Letters or EIRs on record.

Related Companies (10)

Companies with similar regulatory profiles, compliance history, and operations.

Jerome Bertherat
Yohann Loriot, M.D.
Patrick R. Niaudet
Jean-Jacques Kiladjian, M.D., PhD
Lionel Rostaing, MD/PhD
Danielle M.C. Brouquieres, M.D.
Thierry Facon M.D.
Reckitt Benckiser France
Jean Valere Malfuson
Stephane Oudard, MD
Company Information

Name

Ligne St. Barth SAS

FEI Number

3003233369

Address

Lorient, route de Saline, St Barthelemy, France

Country

France

ID: dda88719-44b7-467e-88a7-582aa47f8b6e

KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.